BRIEF published on 08/08/2024 at 07:35, 2 years ago Evotec fait progresser son partenariat en neurosciences avec Bristol Myers Squibb Partenariat Recherche Evotec Neurosciences Bristol Myers Squibb
PRESS RELEASE published on 08/08/2024 at 07:30, 2 years ago Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb Evotec SE announces progress in strategic neuroscience partnership with Bristol Myers Squibb, receiving US$ 25 million payment for further research on neurodegenerative diseases Evotec SE Research Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Partnership
BRIEF published on 08/07/2024 at 13:05, 2 years ago Evotec SE to Announce First Half-Year 2024 Results on 14 August 2024 Financial Results Conference Call Evotec SE Webcast First Half-year 2024
BRIEF published on 08/07/2024 at 13:05, 2 years ago Evotec SE annoncera ses résultats du premier semestre 2024 le 14 août 2024 Résultats Financiers Evotec SE Webdiffusion Conférence Téléphonique Premier Semestre 2024
PRESS RELEASE published on 08/07/2024 at 13:00, 2 years ago Evotec SE reports first half-year 2024 results on 14 August 2024 Evotec SE to report first half-year 2024 results on 14 August 2024. Conference call scheduled to discuss financial performance and updates. Webcast available on www.evotec.com/en/investor-relations/financial-publications Conference Call Financial Performance Evotec SE Webcast First Half-year Results
BRIEF published on 08/06/2024 at 21:12, 2 years ago Evotec Provides Updated Fiscal Guidance for 2024 Adjusted EBITDA Revenue Forecast Sustainable Growth 2024 Guidance Evotec
BRIEF published on 08/06/2024 at 21:12, 2 years ago Evotec fournit des orientations fiscales mises à jour pour 2024 EBITDA Ajusté Prévisions De Revenus Evotec Une Croissance Durable Orientation 2024
BRIEF published on 08/06/2024 at 21:09, 2 years ago Evotec SE Updates Financial Guidance for 2024 Adjusted EBITDA Revenue Forecast Financial Guidance Evotec SE R&D Expenditure
BRIEF published on 08/06/2024 at 21:09, 2 years ago Evotec SE met à jour ses prévisions financières pour 2024 Evotec SE EBITDA Ajusté Conseils Financiers Prévisions De Revenus Dépenses De R&D
PRESS RELEASE published on 08/06/2024 at 21:07, 2 years ago Evotec provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting moderate revenue growth, reduced R&D expenditures, and adjusted EBITDA; aims for sustainable profitable growth amid market challenges Adjusted EBITDA Revenue Growth Evotec SE Guidance Update R&D Expenditures
Published on 08/19/2026 at 09:05, 12 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 07:00, 2 hours 17 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 04:00, 5 hours 17 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 10 hours 7 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 13 hours 32 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:00, 15 hours 17 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 15 hours 32 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 22 hours 1 minute ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 22 hours 1 minute ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 13 hours ago Aéroports de Paris S.A - July 2026 traffic figures
